Quality of the Cardio-pulmonary Resuscitation
Cardiopulmonary Resuscitation; Epidemiology, Quality, Survival and Injuries.
3 other identifiers
observational
400
1 country
1
Brief Summary
Patients having sudden cardiac arrest have very poor prognosis. It is devastating for patient and family. But also very expensive for nations economics when working-age people die or disable due to cardiac arrest. Recent studies have shown that high quality of cardiopulmonary resuscitation (CPR) and minimized delays increases the survival after cardiac arrest. In this objective prospective study we will use Zoll´s X Series defibrillator on every emergency medicine systems (EMS´s) unit in Pirkanmaa area, Finland, to collect information on CPR quality. Real CPR Help® will collect the information on depth, frequency and pauses during CPR. We will make an Utstein analysis on OHCA during one year period and compare the results on Utstein analysis made in the same area on 2013-2014. We will analyse the quality of CPR and compare it to the outcome from OHCA and neurological outcome 3 months after resuscitation. In addition we will analyse the CPR related injuries and compare these to the compression depth and number of persons performing CPR. In one part of the study we will evaluate the incidence of OHCA in different risk areas of Pirkanmaa and analyse the influence of time delay and location to the outcome out of hospital and neurological outcome 3 months after resuscitation. We will also analyse if the time of post-resuscitation care before getting to the hospital or stenosis in carotid artery affects the outcome from OHCA and neurological outcome 3 months after resuscitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 3, 2022
CompletedFirst Posted
Study publicly available on registry
February 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedFebruary 22, 2022
February 1, 2022
1.2 years
January 3, 2022
February 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
QualityCPR
The success rate of current guidelines (depth and frequency of chest compression, epidemiology)
1 year
Neurological survival after CA
Neurological survival after CA
3 months after OHCA
Secondary Outcomes (4)
CPR related injuries
1 year
Stenosis of the carotid artery
3 months after OHCA
the dispatch calls concerning OHCA
1 year
the quality of the postresuscitation care
3 months after OHCA
Study Arms (3)
Cardiac arrest
All patients having sudden cardiac arrest out-of-hospital in Pirkanmaa, Finland
ResusInj
OHCA survivors having CPR related injuries or carotid stenosis analyzed by CT
ResusCPC
OHCA survivors neurological outcome
Eligibility Criteria
All cardiac arrest patients in Etelä-Pohjanmaa and Pirkanmaa, Finland
You may qualify if:
- cardiac arrest
- \> 18 years of age
You may not qualify if:
- \< 18 years of age
- prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampere University hospital
Tampere, 33521, Finland
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Piritta Setälä, PhD
Tampere University Hospital
- STUDY DIRECTOR
Sanna Hoppu, PhD
Tampere University Hospital
- PRINCIPAL INVESTIGATOR
Jyrki Ollikainen, MD
Tampere University Hospital
- STUDY DIRECTOR
Kati Järvelä, PhD
Tampere University Hospital
- PRINCIPAL INVESTIGATOR
Valtteri Järvenpää, MB
Tampere University Hospital
- STUDY DIRECTOR
Ville Jalkanen, PhD
Tampere University Hospital
- STUDY DIRECTOR
Joonas Tirkkonen, PhD
Tampere University Hospital
- STUDY DIRECTOR
Heini Huhtala, PhD
Tampere University
- STUDY DIRECTOR
Mika Martiskainen, PhD
Finnish Institute for Health and Welfare
- STUDY DIRECTOR
Riikka Nevalainen, MD
Tampere University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2022
First Posted
February 22, 2022
Study Start
January 1, 2022
Primary Completion
March 31, 2023
Study Completion
July 1, 2023
Last Updated
February 22, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share